Scott Alexander presents a case for skepticism about psychedelic therapy in psychiatry, outlining seven points of concern while still supporting further research.
Longer summary
Scott Alexander discusses reasons for skepticism about the potential of psychedelic therapy in psychiatry. He outlines seven main points of concern: small studies by enthusiasts leading to unreplicable results, the tendency for all psychotherapies to have amazing success stories, comparison with ketamine's underwhelming results, the case of NSI-189 which failed in trials despite anecdotal success, the lack of obvious effects given widespread psychedelic use, the possibility that insights from psychedelics are illusory, and potential FDA restrictions limiting access and effectiveness. Despite these concerns, Scott supports psychedelic research and hopes to be proven wrong.
Shorter summary